Extendicare Announces 2026 Second Quarter Results
Markham, Ontario--(Newsfile Corp. - August 6, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") today reported results for the three and six months ended June 30, 2026. Second Quarter 2026 Highlights Adjusted EBITDA(1) increased by $28.5 million or 71.7% from Q2 2025 to $68.3 million, driven primarily by contributions from the acquisitions of CBI Home Health and Closing the Gap, as well as continued
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 5:00 PM EDT | Extendicare Inc.
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
King of Prussia, Pennsylvania--(Newsfile Corp. - August 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminat
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 4:05 PM EDT | Phio Pharmaceuticals Corp.
WELL Health Achieves Record Quarterly Revenue Milestone of $400 Million in Q2-2026, Driven by 32% Revenue Growth of Canadian Patient Services, and Raises 2026 Annual Guidance
WELL achieved quarterly revenues of $400.4 million in Q2-2026, an increase of 12% as compared to Q2-2025, driven by strong growth in the Company's Canadian Patient Services Business where quarterly revenue increased by 32% to $151.6 million in Q2-2026 as compared to Q2-2025. WELL achieved Adjusted EBITDA(1) of $48.1 million in Q2-2026, a decrease of 3% as compared to Q2-2025, representing an Adjusted EBITDA Margin(1) of 12%. The decrease reflects the impact
Technology, Computer Software, Healthcare and Hospitals, Health
2026-08-06 4:00 PM EDT | WELL Health Technologies Corp.
Jones Healthcare Group Expands Integrated Packaging Capabilities With Thermoforming Acquisition
London, Ontario--(Newsfile Corp. - August 6, 2026) - Jones Healthcare Group has acquired an operating thermoforming facility and related business assets in Brampton, Ont., adding in-house production of custom-formed packaging components to its integrated offering. The acquisition includes the facility, equipment and an experienced team of colleagues who will join Jones Healthcare. The addition complements the company's existing expertise in printed packaging components, contract packagi
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 10:30 AM EDT | Jones Healthcare Group
Joseph N. Savasta Named 2026 PBMI Innovator Award Recipient
New York, New York--(Newsfile Corp. - August 6, 2026) - HarmonyRx is proud to announce that its Chief Executive Officer, Joseph N. Savasta, has been selected as a recipient of the 2026 PBMI Innovator Award, presented by the Pharmacy Benefit Management Institute (PBMI) and Managed Healthcare Executive. The PBMI Innovator Award recognizes individuals who are driving meaningful change within the pharmacy benefits industry through innovation, leadership and a commitment to imp
2026-08-06 9:10 AM EDT | HarmonyRx
NuGen Announces Non-Binding LOI to Acquire Sol-Millennium Canada
Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce it has entered a non-binding letter of intent ("LOI") with Sol-Millennium Medical HK Limited ("SolM HK"), the sole shareholder of Sol-Millenium Canada Inc. ("SolM"), dated August 5, 2026 to acquire all of the issued and outstanding common shares of SolM (the "Proposed Transaction"). Each party is curre
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-06 8:07 AM EDT | NuGen Medical Devices Inc.
Cheelcare Invited to Numotion Commercial Growth Summit
Markham, Ontario--(Newsfile Corp. - August 6, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it has been invited to participate in the Numotion Commercial Growth Summit, scheduled for August 12-14, 2026, in Denver, Colorado. The Commercial Growth Summit brings together clinicians, Assistive Technology Professionals (ATP's), regional decision-makers, and industry leaders from acros
2026-08-06 7:30 AM EDT | Cheelcare Inc.
Rise Nano Optics Ltd. Announces AGSM Results
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) ("Rise" or the "Company"), is pleased to announce that all resolutions were passed at the annual general and special meeting of shareholders (the "AGSM") held yesterday in person at 10:00 am (Pacific Time). Annual General and Special Meeting Results A total of 16,027,785 common shares in the capital of the Company ("Common Shares
2026-08-06 7:00 AM EDT | Rise Nano Optics Ltd.
Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities
Winter Park, Florida--(Newsfile Corp. - August 5, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced that it will host a private dinner for physicians and investors on Wednesday, August 5, 2026, at 7:00 PM at Christner's Steakhouse.
Healthcare and Hospitals, Health
2026-08-05 4:30 PM EDT | Adia Med Inc.
Psyched Wellness Announces Secured Term Loan
Toronto, Ontario--(Newsfile Corp. - August 5, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together the "Lenders") for an aggregate principal am
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-08-05 9:00 AM EDT | Psyched Wellness Ltd.
Orange Insurance Services Surpasses Launch Goal Ahead of August Market Debut
Chicago, Illinois--(Newsfile Corp. - August 5, 2026) - Orange Underwriters, LLC DBA Orange Insurance Services ("Orange"), a technology-driven managing general agency (MGA) focused on Florida's non-standard personal automobile insurance market, today announced that it has exceeded a major pre-launch milestone by securing commitments from 50 independent insurance agencies ahead of its planned August launch. Based on the strong pace of appointments and growing market demand, the company n
2026-08-05 9:00 AM EDT | HPN Holdings, Inc.
Britannia Announces Normal Course Issuer Bid
Toronto, Ontario--(Newsfile Corp. - August 5, 2026) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") announces that further to its news release dated May 21, 2026, the Company will commence a normal course issuer bid ("NCIB") to purchase for cancelation, from time to time over a 12-month period starting August 10, 2026, common shares ("Common Shares") of the Company in an aggregate amount of up to 8,112,717 Common Shares, representing 5% of Britannia's issued and outs
Biotechnology, Household / Consumer / Cosmetics, Health, Cannabis Ancillary Service Provider
2026-08-05 8:30 AM EDT | Britannia Life Sciences Inc
Custom Health to Acquire Spencer Health Solutions, Strengthening Its Medication Management Infrastructure at Home
Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's pharmacist-led medication management platform with the spencer® in-home smart dispensing and monitoring system, bringing an important in-home medication technology capability fully in-house and further strengthening Custom Health's medication management at home. The Transaction is expected to expand the Corporation's margins by elimi
Technology, Pharmaceuticals, Health
2026-08-05 6:00 AM EDT | Custom Health Holdings Inc.
Rhelion Life Sciences Corp. Commences Trading Under New Name and Ticker Symbol RHEL on the CSE
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (OTCQB: TRUFF) (FSE: 4YX) ("Rhelion" or the "Company") is pleased to announce that it has completed its corporate name change from Red Light Holland Corp. to Rhelion Life Sciences Corp. and changed its ticker symbol on the Canadian Securities Exchange (the "CSE") from "TRIP" to "RHEL" (collectively, the "Name and Ticker Change"). The Company's common shares (the "
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-08-04 9:00 PM EDT | Rhelion Life Sciences Corp.
PreveCeutical Closes Fourth Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated July 27, 2026, June 12, 2026, May 12, 2026 and April 22, 2026 (the "Prior News Releases"), it has closed a fourth tranche (the "Fourth Tranche") of its previously announced non-brokered private placement (the "Offering"),
Biotechnology, Pharmaceuticals, Health
2026-08-04 5:20 PM EDT | PreveCeutical Medical Inc.
AAMI Announces neXus 2027 Advisory Council and Location
Arlington, Virginia--(Newsfile Corp. - August 4, 2026) - The Association for the Advancement of Medical Instrumentation (AAMI) officially announces the members of its Advisory Council and location for the leading medical device industry standards conference held in 2027. The 2027 AAMI neXus will be the premier gathering of the medical device, safety, and regulato
2026-08-04 8:50 AM EDT | Association for the Advancement of Medical Instrumentation
Glow Lifetech Announces Expansion into Quebec, Marking Significant New Market Opportunity in National Growth Strategy
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce its expansion into the Quebec cannabis market, launching its .decimal™ brand across the province beginning August 2026. The expansion marks the Company's entry into one of Canada's largest and most strategically important cannabis markets and represents a significant milestone in Glow's national expansion strategy.
2026-08-04 7:30 AM EDT | Glow Lifetech Corp.
TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback
Clearwater, Florida--(Newsfile Corp. - August 4, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF), a technology-enabled healthcare and digital pharmacy platform, today announced the launch of its new brand platform and digital experience, designed around the needs of modern patients. Shaped by insights gathered from patients over the past two years, the launch represents a significant investment in building a healthcare bra
Healthcare and Hospitals, Health
2026-08-04 7:30 AM EDT | TelyRx
Rise Nano Optics Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - Rise Nano Optics Ltd. (CSE: EYE) (OTCQB: RNOLF) ("Rise" or the "Company") a health technology company advancing vision care through patented nanotechnology lens solutions, today announced that its common shares have been approved to commence trading on the OTCQB Venture Market, operated by OTC Markets Group Inc. The Company's common shares are also now DTC eligible, enhancing the accessibilit
2026-08-04 7:00 AM EDT | Rise Nano Optics Ltd.
Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL
Northvale, New Jersey--(Newsfile Corp. - August 4, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Requip XL® (Ropinirole Extended-Release Tablets USP), with strengths of 2 mg, 4 mg, 6 mg, 8 mg, and 12 mg tablets. Ropinirole belongs to a class of drugs known as a non-ergoline dopamine agonist used to treat P
Healthcare and Hospitals, Pharmaceuticals, Health
2026-08-04 7:00 AM EDT | Elite Pharmaceuticals, Inc.